Z-0186-2014 Class II Terminated

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA device recall Z-0186-2014 was initiated by Fresenius Medical Care Holdings, Inc. on Aug 29, 2013 and is designated Class II. Reason for recall: Updated Instructions for Use: Bloodline connections not tightened per instructions in the operator's manual may disconnect and lead to blood loss The recall status is terminated (terminated Feb 11, 2021). Affected quantity: 508,029 cases.

Recall details

Product Type
Devices
Report Date
Nov 20, 2013
Initiation Date
Aug 29, 2013
Termination Date
Feb 11, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
508,029 cases

Product description

Combiset Blood Line Hemodialysis use Catalog Number: 03-2622-3. Intended for use as the extracorporeal blood circuit during Hemodialysis and is indicated for use with conventional and high flux negative pressure hemodialyzer equipment.

Reason for recall

Updated Instructions for Use: Bloodline connections not tightened per instructions in the operator's manual may disconnect and lead to blood loss

Distribution pattern

Worldwide Distribution-USA (nationwide) and the country of Canada.

Code information

All lot codes

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0186-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0186-2014. Report a data issue: hello@regdatalab.com.